COVID-19 has dramatically revitalized investor interest in the healthcare sector over the past year. The market has seen the flow of smart money into all aspects of healthcare in the past 12 months. The breakthrough of the mRNA platform during the vaccine developments by Moderna and Biontech has led to the potential use of the technology in battling cancer and other illnesses in the future. We are also seeing more interconnection between technology and healthcare stocks. The rise of tele-medicine and virtual health, and other digital innovations further shaped the healthcare market. It is important for these emerging companies to expand their horizons to other markets like Asia, to look for investments and/or collaborations.
The GCFF Asia Healthcare Investment Conference 2021 will be the premier event to connect HNW, institutional and industrial investors in Asia Pacific to the latest investment opportunities in the healthcare sector.
Companies that are in the biotech, medical device, pharmaceutical, and digital health secorts with strong growth potential, should consider presenting at this conference. If you know a company that may be a good fit, please contact us for more information.
In this Asia investor focused event, participating companies will have the benefit of presenting to the qualified investors in Asia who have strong interests in the healthcare sector. These investors will include high-net-worth individuals, institutional investors, private family offices or industrial corporate investor groups. This is an invitation-only event with the focus on regions including China, Hong Kong, Taiwan and Singapore.
This will be the perfect opportunity for companies in the healthcare sector to expand their presence with the growing number of investors in the Asia Pacific region. If you are interested in attending this event as an investor, please contact us for more info.